scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...877298T |
P356 | DOI | 10.1371/JOURNAL.PONE.0077298 |
P8608 | Fatcat ID | release_7xrirtspmvfztecabwqf5glday |
P3181 | OpenCitations bibliographic resource ID | 581185 |
P932 | PMC publication ID | 3796464 |
P698 | PubMed publication ID | 24155939 |
P5875 | ResearchGate publication ID | 258041682 |
P50 | author | Judith Stift | Q58538468 |
Hans-Peter Dienes | Q114665089 | ||
P2093 | author name string | Dragan Maric | |
Stephen M Feinstone | |||
Abeba Tesfaye | |||
Qingwen Cui | |||
P2860 | cites work | Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus | Q27469355 |
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge | Q27472882 | ||
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment | Q27490974 | ||
Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes | Q27861119 | ||
RAG-1-deficient mice have no mature B and T lymphocytes | Q28592133 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Hepatitis C virus replication in mice with chimeric human livers | Q29620650 | ||
Preliminary study of two antiviral agents for hepatitis C genotype 1. | Q34030288 | ||
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models | Q34140014 | ||
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. | Q34307135 | ||
Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma | Q35677500 | ||
Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes | Q35829671 | ||
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice | Q36115197 | ||
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer | Q36812745 | ||
An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer | Q37620586 | ||
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses | Q37825527 | ||
Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection | Q37858630 | ||
Animal models for the study of hepatitis C virus infection and related liver disease | Q38005793 | ||
Animal models for hepatitis C. | Q38086749 | ||
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial | Q42857015 | ||
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice | Q42998132 | ||
Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay | Q43040150 | ||
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders | Q43041150 | ||
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers | Q45794085 | ||
Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. | Q50706733 | ||
Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes. | Q51671636 | ||
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. | Q52221306 | ||
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. | Q52507854 | ||
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. | Q53454854 | ||
P275 | copyright license | Creative Commons CC0 License | Q6938433 |
P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis B | Q6853 |
P304 | page(s) | e77298 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Chimeric mouse model for the infection of hepatitis B and C viruses | |
P478 | volume | 8 |
Q54988623 | Animal Models to Study Hepatitis C Virus Infection. |
Q26797836 | Animal models for the study of HCV |
Q38788783 | Assessing the therapeutic potential of lab-made hepatocytes |
Q35998324 | Determinants of hepatitis B and delta virus host tropism. |
Q39215858 | Development of mouse models for analysis of human virus infections |
Q64058174 | Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus |
Q35140067 | Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model |
Q38778496 | Experimental models of hepatitis B and C - new insights and progress |
Q91907310 | Generation of functional human hepatocytes in vitro: current status and future prospects |
Q28384465 | HCV infection-associated hepatocellular carcinoma in humanized mice |
Q35270150 | Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war? |
Q92856183 | Humanized Mouse Models for the Study of Hepatitis C and Host Interactions |
Q64966438 | In Vivo Model Systems for Hepatitis B Virus Research. |
Q26799933 | Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems |
Q38534533 | Modeling hepatitis B virus infection, immunopathology and therapy in mice |
Q38354353 | Modeling malaria in humanized mice: opportunities and challenges |
Q27469038 | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance |
Q89108940 | Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research |
Q26991875 | Murine models of hepatitis C: what can we look forward to? |
Q26783920 | Single and Multiple Gene Manipulations in Mouse Models of Human Cancer |
Q35685210 | Study of viral pathogenesis in humanized mice |
Q40409293 | Studying HBV Infection and Therapy in Immune-Deficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (Fah) Knockout Mice Transplanted with Human Hepatocytes |
Q39545359 | The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses. |
Q41116856 | Viral non-coding RNA inhibits HNF4α expression in HCV associated hepatocellular carcinoma |
Q34175159 | Visualizing hepatitis C virus infection in humanized mice |